Most Recent
Banksia judge made no allowance for ‘youth and inexperience’ of Mark Elliott’s son, appeal says
The judge who made findings against the son of the mastermind behind the Banksia class action scam may have formed strong views about the 27-year-old's role before he testified and used the flawed suggestion that he was his father's right-hand man as an "evidential gap filler", an appeals court has been told.
ANZ hit with ASIC action over $18.5B home loan ‘introducer’ program
The Australian Securities and Investments Commission has launched court proceedings against ANZ alleging the banking giant's home loan 'introducer' referral program breached credit laws.
Controversial class action bill passes House by slim margin
The federal government's latest class action reform bill that would effectively cap legal fees and funding commissions has narrowly passed the House of Representatives.
Greensill Bank says IAG unit owes $48.5M under trade credit policy
The insolvency administrator of Germany-based Greensill Bank AG has launched court proceedings against Insurance Australia Limited seeking US$35 million allegedly owed under a policy indemnifying the collapsed financial services firm for unrecovered debts.
Novartis unit Sandoz sues to revoke Bayer’s patents for blood thinner Xarelto
Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.
Romeo’s settles two underpayments class actions
Supermarket chain Romeo's has reached a settlement in two class actions alleging staff were underpaid, but details of the agreements are scant.
Banksia class action barristers declare bankruptcy after $21.7M judgment
Two former barristers ordered to pay at least $21.7 million in damages and costs for their role in a fraudulent scheme to pocket a windfall from the Banksia Securities class action have filed for bankruptcy.
Pfizer wins more docs in preliminary discovery saga over Enbrel biosimilar
Five years into a preliminary discovery application for a potential patent infringement lawsuit over a biosimilar of its Enbrel medication, Pfizer has partially succeeded in obtaining further documents from Samsung Bioepis.
Freezing orders extended against developer James Raptis in $110M tax case
A judge has extended asset freezing orders until next year in a $109.5 million case brought by the tax office against Gold Coast property developer James Raptis and his companies.
Man sues Seven for wrongly naming him Cleo Smith abduction suspect
A Nyamal man mistakenly identified by the Seven Network as the suspect in the abduction of four-year-old Cleo Smith in Western Australia is suing the broadcaster for defamation.